These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6126392)

  • 1. Isolation and enrichment of cells resistant to iron accumulation from carcinogen-induced rat liver altered foci.
    Mori H; Mu B; Williams GM
    Exp Mol Pathol; 1982 Aug; 37(1):101-10. PubMed ID: 6126392
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen.
    Williams GM; Watanabe K
    J Natl Cancer Inst; 1978 Jul; 61(1):113-21. PubMed ID: 276621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis.
    Hirota N; Williams GM
    Am J Pathol; 1979 May; 95(2):317-28. PubMed ID: 222150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the peroxisome proliferator di(2-ethylhexyl)phthalate on enzymes in rat liver and on carcinogen-induced liver altered foci in comparison to the promoter phenobarbital.
    Maruyama H; Tanaka T; Williams GM
    Toxicol Pathol; 1990; 18(2):257-67. PubMed ID: 1975953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline-induced siderosis.
    Williams GM; Yamamoto RS
    J Natl Cancer Inst; 1972 Sep; 49(3):685-92. PubMed ID: 4647491
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
    Williams GM; Katayama S; Ohmori T
    Carcinogenesis; 1981; 2(11):1111-7. PubMed ID: 6119166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro measurement of resistance to phalloidin and gamma-glutamyltransferase of carcinogen-induced preneoplastic hepatocytes of rats.
    Sawada N; Furukawa K; Tsukada H
    J Natl Cancer Inst; 1982 Sep; 69(3):683-6. PubMed ID: 6125619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of viable putative preneoplastic hepatocytes to the livers of syngeneic host rats.
    Laishes BA; Farber E
    J Natl Cancer Inst; 1978 Aug; 61(2):507-12. PubMed ID: 28422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature of early appearing, carcinogen-induced liver lesions to iron accumulation.
    Williams GM; Klaiber M; Parker SE; Farber E
    J Natl Cancer Inst; 1976 Jul; 57(1):157-65. PubMed ID: 1003498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions.
    Watanabe K; Williams GM
    J Natl Cancer Inst; 1978 Nov; 61(5):1311-4. PubMed ID: 280716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action.
    Furuya K; Maeura Y; Williams GM
    Toxicol Pathol; 1984; 12(2):136-42. PubMed ID: 11478314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased fibronectin in rat liver altered foci and adenomas induced by N-2-fluorenylacetamide.
    Maruyama H; Tanaka T; Gebhardt R; Berghem L; Williams GM
    Lab Invest; 1988 Jun; 58(6):630-5. PubMed ID: 3379912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-glutamyl transpeptidase: a positive marker for cultured rat liver cells derived from putative premalignant and malignant lesions.
    Laishes BA; Ogawa K; Roberts E; Farber E
    J Natl Cancer Inst; 1978 May; 60(5):1009-16. PubMed ID: 25344
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation.
    Hirota N; Williams GM
    Cancer Res; 1982 Jun; 42(6):2298-309. PubMed ID: 7074612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of acetylaminofluorene--DNA adduct formation in enzyme-altered foci of rat liver.
    Huitfeldt HS; Hunt JM; Pitot HC; Poirier MC
    Carcinogenesis; 1988 Apr; 9(4):647-52. PubMed ID: 2895693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early histochemical markers of hepatocarcinogenesis].
    Vinarchuk MP; Bykorez AI
    Eksp Onkol; 1984; 6(1):11-6. PubMed ID: 6209085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential functional and morphological alterations during hepatocarcinogenesis induced in rats by feeding of a low dose of 2-acetylaminofluorene.
    Stenbäck F; Gebhardt R; Sirma H; Garbay JM; Williams GM
    Toxicol Pathol; 1994; 22(6):620-32. PubMed ID: 7732279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis.
    Cameron R; Kellen J; Kolin A; Malkin A; Farber E
    Cancer Res; 1978 Mar; 38(3):823-9. PubMed ID: 23897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The initiation of gamma-glutamyltranspeptidase positive foci in the rat liver by N-hydroxy-2-acetylaminofluorene. The effect of the sulfation inhibitor pentachlorophenol.
    Meerman JH
    Carcinogenesis; 1985 Jun; 6(6):893-7. PubMed ID: 2860981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver.
    Tatematsu M; Nagamine Y; Farber E
    Cancer Res; 1983 Nov; 43(11):5049-58. PubMed ID: 6137276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.